The Association of Atorvastatin Therapy With COVID-19 Outcomes and Mortality

Hamid Reza Aghaei Meybodi; Seyedeh Zahra Fotook Kiaee; Marjan Akhavan; Samira Abbasloo; Mahnaz Pejman Sani

Volume 7, Issue 1 , February 2022, , Pages 11-16

http://dx.doi.org/10.34172/hpr.2022.03

Abstract
  Background: The world is still witnessing a largely ongoing spread of coronavirus disease 2019 (COVID-19); therefore, the scientific findings in this area need to be shared promptly.Objectives: This study aimed to assess the usefulness of Atorvastatin treatment in reducing COVID-19 mortality in patients ...  Read More

Immunosuppressive Drugs and Kidney Post-transplant Diabetes Mellitus

Ismael Bilal Ismael; Sarhang Hasan Azeez

Volume 4, Issue 2 , June 2019, , Pages 50-56

http://dx.doi.org/10.15171/hpr.2019.09

Abstract
  Background: As the rate of renal transplantation increases, more immunosuppressive drugs such as cyclosporine A (CsA) are consumed, particularly during the early months following transplantation, leading to post-transplant diabetes mellitus (PTDM) which can cause death. Objective: The present study examined ...  Read More